A new hypothesis on autism, more data on the "fat genes," the problem of oral health, rethinking autonomy for the mentally ill and more from our Daily Briefing.
Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.
When controversial bioethicist Glenn McGee quit his job as chief ethics advisor to Houston-based Celltex Therapeutics in February, the controversy over the company was on the verge of dying down. Until Celltex threatened a major public university and the very concept of free speech.
It is three in the morning and Philip, 27, wakes up from a nightmare that he soon forgets. Vivid dreams and dizziness are recurring experiences, side effects he attributes to taking Atripla, a pill he consumes daily because he has AIDS.
A confluence of factors including an inflexible regulatory enviroment that discourages research and discovery, a paltry research pipeline for drugs for the most serious illnesses, and a tendency for physicians to unnecessarily prescribe antibiotics for routine aches and pains is largely responsible for the rise of antibiotic-resistant infections in humans, speakers at a major conference on infectious diseases this week announced.
A year after the Fukushima nuclear crisis, restaurant health ratings and salmonella outbreaks, hospital infection news and more from our Daily Briefing.
To battle obesity, West Virginia Schools teachers are implementing 15 extra minutes of physical activity into each day.
Regenerative Sciences, a medical company that pioneered a procedure to treat orthopedic injuries using patients’ own stem cells, is fighting the Food and Drug Administration tooth and nail over a claim that human cells should be federally regulated as drugs, in a landmark case that has far-reaching implications for the future of regenerative medicine.
Toxic hair straightening, a new drug for cystic fibrosis, a religious battle over birth control and more from our Daily Briefing.
